Literature DB >> 28433110

Animal models of Wilson disease.

Valentina Medici1, Dominik Huster2.   

Abstract

Wilson disease (WD) is caused by ATPase copper-transporting beta (ATP7B) mutations and results in copper toxicity in liver and brain. Although the defective gene was identified in 1993, the specific mechanisms underlying copper toxicity and the remarkable phenotypic diversity of the disease are still poorly understood. Animal models harboring defects in the ATP7B homolog have helped to reveal new insights into pathomechanisms of WD. Four rodent models with ATP7B gene defects have been described - the Long-Evans Cinnamon (LEC) rat, inbred mouse models (toxic milk (tx), the Jackson Laboratory toxic milk (tx-j)), and the genetically engineered ATP7B-/- (knockout) mouse - all of which develop liver disease to different extents. Copper accumulation in parts of the brain accompanied by some neurologic involvement was revealed in LEC rats and tx/tx-j mice, but the pathology is less severe than human neurologic WD. Several dogs show hepatic copper toxicity resembling WD; however, brain involvement has not been observed and the underlying genetic defect is different. These models are of great value for examination of copper distribution and metabolism, gene expression, and investigation of liver and brain pathology. The availability of disease models is essential for therapeutic interventions such as drug, gene, and cell therapy. Findings made by animal studies may facilitate the development of specific therapies to ameliorate WD progression.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATP7B; Wilson disease; animal model; brain; copper toxicity; inherited disease; liver; metabolism

Mesh:

Substances:

Year:  2017        PMID: 28433110     DOI: 10.1016/B978-0-444-63625-6.00006-9

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  5 in total

Review 1.  Determination of copper poisoning in Wilson's disease using laser ablation inductively coupled plasma mass spectrometry.

Authors:  Sabine Weiskirchen; Philipp Kim; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2019-04

2.  Movement Disorder in Wilson Disease: Correlation with MRI and Biomarkers of Cell Injury.

Authors:  Jayantee Kalita; Vijay Kumar; Usha K Misra; Sunil Kumar
Journal:  J Mol Neurosci       Date:  2020-07-13       Impact factor: 3.444

3.  Inhibiting NLRP3 inflammasome activation prevents copper-induced neuropathology in a murine model of Wilson's disease.

Authors:  Jianjian Dong; Xun Wang; Chenchen Xu; Manli Gao; Shijing Wang; Jin Zhang; Haiyang Tong; Lulu Wang; Yongzhu Han; Nan Cheng; Yongsheng Han
Journal:  Cell Death Dis       Date:  2021-01-18       Impact factor: 8.469

4.  System Pharmacology-Based Strategy to Decode the Synergistic Mechanism of GanDouLing for Wilson's Disease.

Authors:  Juan Zhang; Hong Chen; Yuancheng Bao; Daojun Xie; Wenming Yang; Huaizhou Jiang; Ting Dong; Hui Han
Journal:  Evid Based Complement Alternat Med       Date:  2021-01-29       Impact factor: 2.629

5.  Systemic deletion of Atp7b modifies the hepatocytes' response to copper overload in the mouse models of Wilson disease.

Authors:  Abigael Muchenditsi; C Conover Talbot; Aline Gottlieb; Haojun Yang; Byunghak Kang; Tatiana Boronina; Robert Cole; Li Wang; Som Dev; James P Hamilton; Svetlana Lutsenko
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.